| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| Emulating a target trial in case-control designs: an application to statins and colorectal cancer | [1]Barbra A Dickerman, [2]Xabier García-Albéniz, [3]Roger W Logan, [4]Spiros Denaxas, [5]Miguel A Hernán [Full author list] | International Journal of Epidemiology [missing] | DOI: 10.1093/IJE/DYAA144 [ORCID]
PubMed: 32989456 [ORCID]
| colorectal cancer [missing] | 2020-09-29 | |
| Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial | [1]Carlos Fernández-Martos, [2]Carles Pericay, [3]Ferran Losa, [4]Rocio García-Carbonero, [5]Laura Layos, [6]Nuria Rodríguez-Salas, [7]Marta Martin-Richard, [8]Vicente Alonso-Orduña, [9]Ruth Vera, [10]Javier Gallego, [11]Jaume Capdevila, [12]Antonieta Salud, [13]Miquel Nogué, [14]Joan Maurel, [15]Inmaculada Guash, [16]Clara Montagut, [17]Carlos Lopez, [18]Ismael Macias, [19]Rakesh K Jain, [20]Xabier Garcia-Albeniz [Full author list] | JAMA Oncology [missing] | DOI: 10.1001/JAMAONCOL.2019.2294 [ORCID]
PubMed: 31465088 [ORCID]
| aflibercept [missing] | 2019-08-29 | |
| Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02) | [1]Xabier García-Albéniz, [2]Vicente Alonso, [3]Pilar Escudero, [4]Miguel Méndez, [5]Javier Gallego, [6]Jose Ramon Rodríguez, [7]Antonia Salud, [8]Julen Fernández-Plana, [9]Hermini Manzano, [10]Montserrat Zanui, [11]Ester Falcó, [12]Jaime Feliu, [13]Mireia Gil, [14]Carlos Fernández-Martos, [15]Uriel Bohn, [16]Carmen Alonso, [17]Verónica Calderero, [18]Federico Rojo, [19]Miriam Cuatrecasas, [20]Joan Maurel [Full author list] | Oncologist [missing] | DOI: 10.1634/THEONCOLOGIST.2018-0728 [ORCID]
PubMed: 31235483 [ORCID]
| colorectal cancer [missing]; biomarker [missing] | 2019-06-24 | |
| Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial) | [1]Joan Maurel, [2]Santiago Sánchez Cabús, [3]Berta Laquente, [4]Lydia Gaba, [5]Laura Visa, [6]Joan Fabregat, [7]Ignacio Povés, [8]Susana Roselló, [9]Roberto Díaz-Beveridge, [10]Marta Martín-Richard, ..., [19]Josep Antoni Bombí, [20]Angels Ginés, [21]Xabier García-Albéniz, [22]Laureano Fernández-Cruz [Full author list] | Cancer Chemotherapy and Pharmacology [missing] | DOI: 10.1007/S00280-018-3682-9 [ORCID]
PubMed: 30225601 [ORCID]
| pancreatic cancer [missing] | 2018-09-17 | |
| Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients | [1]Vicente Alonso, [2]Pilar Escudero, [3]Carlos Fernández-Martos, [4]Antonia Salud, [5]Miguel Méndez, [6]Javier Gallego, [7]Jose-R Rodriguez, [8]Marta Martín-Richard, [9]Julen Fernández-Plana, [10]Hermini Manzano, [11]José-Carlos Méndez, [12]Monserrat Zanui, [13]Esther Falcó, [14]Mireia Gil-Raga, [15]Federico Rojo, [16]Miriam Cuatrecasas, [17]Jaime Feliu, [18]Xabier García-Albéniz, [19]Joan Maurel [Full author list] | Neoplasia [missing] | DOI: 10.1016/J.NEO.2018.05.004 [ORCID]
PubMed: 29842993 [ORCID]
| colorectal cancer [missing]; cetuximab [missing]; metastatic colon cancer [missing] | 2018-05-26 | |
| Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer | [1]Jordi Codony-Servat, [2]Miriam Cuatrecasas, [3]Elena Asensio, [4]Carla Montironi, [5]Anna Martínez-Cardús, [6]Mercedes Marín-Aguilera, [7]Carlos Horndler, [8]Eva Martínez-Balibrea, [9]Michele Rubini, [10]Pedro Jares, ..., [25]Aleix Prat, [26]Rafael Rosell, [27]Xabier García-Albéniz, [28]Jordi Camps, [29]Joan Maurel [Full author list] | British Journal of Cancer [missing] | DOI: 10.1038/BJC.2017.279 [ORCID]
PubMed: 29123263 [ORCID]
| colorectal cancer [missing] | 2017-11-09 | |
| Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients | [1]Miguel Caballero-Baños, [2]Daniel Benitez-Ribas, [3]Jaime Tabera, [4]Sara Varea, [5]Ramon Vilana, [6]Luis Bianchi, [7]Juan Ramón Ayuso, [8]Mario Pagés, [9]Gemma Carrera, [10]Miriam Cuatrecasas, [11]Marta Martin-Richard, [12]Joan Cid, [13]Miquel Lozano, [14]Antoni Castells, [15]Xabier García-Albéniz, [16]Joan Maurel, [17]Ramon Vilella [Full author list] | European Journal of Cancer [missing] | DOI: 10.1016/J.EJCA.2016.06.008 [ORCID]
PubMed: 27428073 [ORCID]
| colorectal cancer [missing]; dendritic cell [missing]; colorectal carcinoma [missing]; phase II clinical trial [missing] | 2016-07-15 | |
| Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study | [1]Joan Maurel, [2]Antonio López-Pousa, [3]Silvia Calabuig, [4]Silvia Bagué, [5]Xavier Garcia Del Muro, [6]Xavier Sanjuan, [7]Jordi Rubió-Casadevall, [8]Miriam Cuatrecasas, [9]Javier Martinez-Trufero, [10]Carlos Horndler, [11]Joaquin Fra, [12]Claudia Valverde, [13]Andrés Redondo, [14]Andrés Poveda, [15]Isabel Sevilla, [16]Nuria Lainez, [17]Michele Rubini, [18]Xabier García-Albéniz, [19]Javier Martín-Broto, [20]Enrique de Alava [Full author list] | Clinical Sarcoma Research [missing] | DOI: 10.1186/S13569-016-0050-6 [ORCID]
PubMed: 27358721 [ORCID]
| phosphorylation [missing] | 2016-06-29 | |
| Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS). | [1]Jordi Rubió-Casadevall, [2]Javier Martinez-Trufero, [3]Xabier Garcia-Albeniz, [4]Silvia Calabuig, [5]Antonio Lopez-Pousa, [6]Javier Garcia Del Muro, [7]Joaquin Fra, [8]Andrés Redondo, [9]Nuria Lainez, [10]Andrés Poveda, [11]Claudia Valverde, [12]Ana De Juan, [13]Isabel Sevilla, [14]Antonio Casado, [15]Raquel Andres, [16]Josefina Cruz, [17]Javier Martin-Broto, [18]Joan Maurel, [19]Spanish Group for Research on Sarcoma (GEIS) [Full author list] | Annals of Surgical Oncology [missing] | DOI: 10.1245/S10434-014-4360-8 [ORCID]
PubMed: 25608769 [ORCID]
| imatinib [missing] | 2015-01-22 | |
| Why post-progression survival and post-relapse survival are not appropriate measures of efficacy in cancer randomized clinical trials | [1]Xabier García-Albéniz, [2]Joan Maurel, [3]Miguel A Hernán [Full author list] | International Journal of Cancer [missing] | DOI: 10.1002/IJC.29278 [ORCID]
PubMed: 25333417 [ORCID]
| | 2014-11-03 | |
| Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation | [1]Xabier García-Albéniz, [2]Rosa Gallego, [3]Ralf Dieter Hofheinz, [4]Gloria Fernández-Esparrach, [5]Juan Ramón Ayuso-Colella, [6]Josep Antoni Bombí, [7]Carles Conill, [8]Miriam Cuatrecasas, [9]Salvadora Delgado, [10]Angels Ginès, ... [Full author list] | World Journal of Gastroenterology [missing] | DOI: 10.3748/WJG.V20.I42.15820 [ORCID]
PubMed: 25400468 [ORCID]
| chemoradiotherapy [missing] | 2014-11-01 | |
| RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy | [1]Virginia Alonso-Espinaco, [2]Miriam Cuatrecasas, [3]Vicente Alonso, [4]Pilar Escudero, [5]Maribel Marmol, [6]Carlos Horndler, [7]Javier Ortego, [8]Rosa Gallego, [9]Jordi Codony-Servat, [10]Xabier Garcia-Albeniz, [11]Pedro Jares, [12]Antoni Castells, [13]Juan J Lozano, [14]Rafael Rosell, [15]Joan Maurel [Full author list] | European Journal of Cancer [missing] | DOI: 10.1016/J.EJCA.2014.04.019 [ORCID]
PubMed: 24833563 [ORCID]
| colorectal cancer [missing]; chemotherapy [missing]; overexpression [missing]; metastatic colon cancer [missing] | 2014-05-12 | |
| Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer | [1]Jordi Codony-Servat, [2]Mercedes Marín-Aguilera, [3]Laura Visa, [4]Xabier García-Albéniz, [5]Estela Pineda, [6]Pedro L Fernández, [7]Xavier Filella, [8]Pere Gascón, [9]Begoña Mellado [Full author list] | The Prostate [missing] | DOI: 10.1002/PROS.22591 [ORCID]
PubMed: 23038213 [ORCID]
| prostate cancer [missing]; interleukins [missing]; docetaxel [missing] | 2012-10-04 | |
| Design and endpoints of clinical and translational trials in advanced colorectal cancer. a proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD). | [1]Gemma Carrera, [2]Xabier Garcia-Albeniz, [3]Juan Ramón Ayuso, [4]Jorge Aparicio, [5]Antoni Castells, [6]Jordi Codony-Servat, [7]Jaime Feliu, [8]David Fuster, [9]Rosa Gallego, [10]Mario Pagés, [11]Ferran Torres, [12]Joan Maurel [Full author list] | Reviews on recent clinical trials [missing] | DOI: 10.2174/157488711795177868 [ORCID]
PubMed: 21241233 [ORCID]
| colorectal cancer [missing] | 2011-05-01 | |
| Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas | [1]Joan Maurel, [2]Ana Sofia Martins, [3]Andrés Poveda, [4]José Antonio López-Guerrero, [5]Ricardo Cubedo, [6]Antonio Casado, [7]Javier Martínez-Trufero, [8]Juan Ramón Ayuso, [9]Antonio Lopez-Pousa, [10]Xabier Garcia-Albeniz, [11]Xavier Garcia del Muro, [12]Enrique de Alava [Full author list] | Cancer [missing] | DOI: 10.1002/CNCR.25111 [ORCID]
PubMed: 20564079 [ORCID]
| doxorubicin [missing]; imatinib [missing] | 2010-08-01 | |
| Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer | [0]Josep Maria Auge Fradera, [1]Rosa Gallego, [2]Jordi Codony-Servat, [3]Xabier García-Albéniz, [4]Enric Carcereny, [5]Raquel Longarón, [6]Angeles Oliveras, [7]Mónica Tosca, [8]Josep Maria Augé, [9]Pedro Gascón, [10]Joan Maurel [Full author list] | Endocrine-Related Cancer [missing] | DOI: 10.1677/ERC-08-0250 [ORCID]
PubMed: 19109398 [ORCID]
| colorectal cancer [missing] | 2008-12-24 | |
| Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients | [1]Joan Maurel, [2]Cristina Nadal, [3]Xabier Garcia-Albeniz, [4]Rosa Gallego, [5]Enric Carcereny, [6]Vanesa Almendro, [7]Maribel Mármol, [8]Elena Gallardo, [9]Josep Maria Augé, [10]Raquel Longarón, [11]Alex Martínez-Fernandez, [12]Rafael Molina, [13]Antoni Castells, [14]Pere Gascón, [14-Q91822902]Josep Maria Auge Fradera [Full author list] | International Journal of Cancer [missing] | DOI: 10.1002/IJC.22799 [ORCID]
PubMed: 17487834 [ORCID]
| colorectal cancer [missing]; colorectal carcinoma [missing] | 2007-09-01 | |